SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
The Neuroscientist
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Mejia, R. O. S.
Right arrow Articles by Friedlander, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mejia, R. O. S.
Right arrow Articles by Friedlander, R. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Caspases in Huntington’s Disease

René O. Sanchez Mejia

Neuroapoptosis Laboratory, Department of Neurosurgery, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts

Robert M. Friedlander

Neuroapoptosis Laboratory, Department of Neurosurgery, Brigham & Women’s Hospital, Harvard Medical School, Boston, Massachusetts, rfriedlander{at}rics.bwh.harvard.edu

Huntington’s disease (HD) is an autosomal dominant condition, resulting from a mutation in huntingtin (htt). Htt is a novel protein, and its normal function is at present not well understood. Nuclear translocation of mutant htt in vitro up-regulates expression of the cell death gene caspase-1. We have demonstrated in a transgenic HD mouse model that caspase-1 and caspase-3 are transcriptionally up-regulated and activated. Underscoring the relevancy of these findings, recent results suggest that caspase-1 is activated in brains of humans with HD. Caspase activation results in the proteolytic cleavage of key cellular targets, including htt, leading to cell dysfunction. Caspase activation leading to cell dysfunction and death correlates with disease progression. In HD-transgenic mice, caspase inhibition resulted in a delayed onset of symptoms, a slowed progression, and prolonged survival. Caspase inhibition is a therapeutic strategy that merits evaluation in humans with HD.

Key Words: Huntington’s disease • Apoptosis • Caspase • Neurodegeneration • Amyotrophic lateral sclerosis

The Neuroscientist, Vol. 7, No. 6, 480-489 (2001)
DOI: 10.1177/107385840100700604
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Varma, R. Cheng, C. Voisine, A. C. Hart, and B. R. Stockwell
Inhibitors of metabolism rescue cell death in Huntington's disease models
PNAS, September 4, 2007; 104(36): 14525 - 14530.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. A. Vincent and S. Mohr
Inhibition of Caspase-1/Interleukin-1{beta} Signaling Prevents Degeneration of Retinal Capillaries in Diabetes and Galactosemia
Diabetes, January 1, 2007; 56(1): 224 - 230.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
B. L. Apostol, K. Illes, J. Pallos, L. Bodai, J. Wu, A. Strand, E. S. Schweitzer, J. M. Olson, A. Kazantsev, J. L. Marsh, et al.
Mutant huntingtin alters MAPK signaling pathways in PC12 and striatal cells: ERK1/2 protects against mutant huntingtin-associated toxicity
Hum. Mol. Genet., January 15, 2006; 15(2): 273 - 285.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Feng, P. Li, C. Salamanca, D. Huntsman, P. C.K. Leung, and N. Auersperg
Caspase-1{alpha} Is Down-regulated in Human Ovarian Cancer Cells and the Overexpression of Caspase-1{alpha} Induces Apoptosis
Cancer Res., October 1, 2005; 65(19): 8591 - 8596.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
M. Peschanski, A.-C. Bachoud-Levi, and P. Hantraye
Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease
Brain, June 1, 2004; 127(6): 1219 - 1228.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
J. M. Kahlenberg and G. R. Dubyak
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release
Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1100 - C1108.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Pagano, Y. Donati, I. Metrailler, and C. Barazzone Argiroffo
Mitochondrial cytochrome c release is a key event in hyperoxia-induced lung injury: protection by cyclosporin A
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L275 - L283.
[Abstract] [Full Text] [PDF]


Advertisement